Latest Breaking News On - Disease modifying therapy - Page 1 : comparemela.com

TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting

TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoUnited kingdomStanford universityRiley boveLawrence steinmanSclerosis international federationPediatrics at stanford universityExchange commissionGlobe newswire tg therapeutics incTg therapeutics incWeill institute of neurosciencesNational multiple sclerosis societyDrug administrationHealthcare products regulatory agencyConsortium of multiple sclerosis centers

GeNeuro Announces Last Patient Last Visit in its Post-COVID Trial and Confirms Top-Line Results by End of June 2024

GeNeuro Announces Last Patient Last Visit in its Post-COVID Trial and Confirms Top-Line Results by End of June 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Arthur rouillEuronext parisPost acute sequelaeDisease modifying therapyPatients with neuropsychiatric symptomsAnke postChief medical officerVictor delouvrierIhr portfolio

Medically, you might be interested in Parkinson s Disease

Dr Ray O’Connor takes a look at the latest clinical studies on Parkinson’s Disease and what’s new in treatment and research on the second most common neurogenerative condition

David bradleyRay oconnorWiley online libraryRayo connorDisease modifying therapyProf david bradleyEnglj medDrug therapyIntern medTranslational medicineMicrobiota approachNew strategyTreat parkinsonGut microbiota approachSystemic inflammationDisease movement disorders

Pharma major Roche launches breakthrough therapy to treat Multiple Sclerosis in India

Pharma major Roche launches breakthrough therapy to treat Multiple Sclerosis in India
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Viraj suvarnaMv padma srivastavaSandeep chitnisOcrevus ocrelizumabDrug administrationCluster head indian leadership teamNational honorarySclerosis society of indiaRoche pharma indiaRelapsing formsPrimary progressiveDisease modifying therapyRelapsing remitting multiple sclerosisPrimary progressive multiple sclerosisDirector cluster headIndian leadership team

Enigma Biomedical - USA Announces Appointment of Hartmuth Kolb, PhD as Chief Scientific Officer

KNOXVILLE, Tenn. Enigma Biomedical USA (EB) today announced the appointment of Hartmuth Kolb, PhD as Chief Science Officer (CSO). Dr. Kolb’s passion for…

City ofUnited kingdomUnited statesSamantha budd haeberleinRick hiattMeilleur technologies incImperial collegeNeuroscience steering committee of the foundationNeuroscience steering committeeNorganic chemistryChief executive officerEnigma biomedical united statesMeilleur technologiesChief medical officerEnigma biomedicalBiomedical united states